Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Last week's biggest large-cap decliners included AeroVironment, DraftKings, AppLovin and Abbott, pressured by news, earnings and analyst actions.
Abbott Laboratories: Double-Digit Earnings Growth Makes It A Buy
08:00am, Sunday, 25'th Jan 2026
Abbott Laboratories is rated 'Buy,' following a recent price drop, driven by Nutrition segment weakness and COVID-19 diagnostics decline. ABT's Medical Devices segment, especially CGM, continues to de
Commerzbank Aktiengesellschaft FI Buys 20,825 Shares of Abbott Laboratories $ABT
05:30am, Sunday, 25'th Jan 2026
Commerzbank Aktiengesellschaft FI lifted its stake in shares of Abbott Laboratories (NYSE: ABT) by 9.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 245,168 s
Cullen Frost Bankers Inc. Has $23.73 Million Stock Position in Abbott Laboratories $ABT
04:56am, Sunday, 25'th Jan 2026
Cullen Frost Bankers Inc. raised its holdings in Abbott Laboratories (NYSE: ABT) by 3.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutiona
Is Abbott's January Pullback a Good Time to Buy?
10:16am, Saturday, 24'th Jan 2026
Abbott Laboratories' NYSE: ABT January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a knee-
Abbott Laboratories: The Market's Overreaction Is The Long-Term Investor's Opportunity
07:30am, Saturday, 24'th Jan 2026
Abbott Laboratories experienced a post-earnings sell-off driven by weakness in its Nutrition segment and a sizable revenue miss. Despite segment headwinds, ABT delivered double-digit bottom-line growt
Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of “Moderate Buy” from Brokerages
03:22am, Saturday, 24'th Jan 2026
Abbott Laboratories (NYSE: ABT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twenty-two analysts that are covering the stock, Marketbeat reports. Three equities
Abbott (ABT) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Friday, 23'rd Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is The Fall In Abbott Stock Justified?
09:35am, Friday, 23'rd Jan 2026
Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, align
Abbott Laboratories: Buy This Dividend King On Sale Now
07:25am, Friday, 23'rd Jan 2026
Last month, Abbott Laboratories hiked its dividend for the 54th consecutive year. The company's FreeStyle Libre and Volt PFA System franchises, as well as its pending acquisition of Exact Sciences, po
Abbott faces India scrutiny in cough syrup abuse investigation, documents show
06:43am, Friday, 23'rd Jan 2026
Indian drugmaker Abbott Healthcare's supply chain is being scrutinised as part of a wider investigation into the alleged misuse of its codeine-based cough syrup which is prone to abuse by addicts, doc
Abbott Laboratories (ABT) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with Strategic Growth Initiatives
04:01pm, Thursday, 22'nd Jan 2026
Release Date: January 22, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Abbott Labora
Abbott Laboratories Raised Prices, Prompting Sales Slump
02:31pm, Thursday, 22'nd Jan 2026
The medical-products maker's shares tumbled after its quarterly profit and sales underwhelmed investors.
Abbott Laboratories (ABT) Q4 2025 Earnings Call Transcript
12:54pm, Thursday, 22'nd Jan 2026
Abbott Laboratories (ABT) Q4 2025 Earnings Call Transcript
Jobless Claims Come in Slightly Higher
12:11pm, Thursday, 22'nd Jan 2026
Jobless Claims Come in Slightly Higher.
